Pituitary somatostatin receptor signaling

被引:150
|
作者
Ben-Shlomo, Anat [1 ]
Melmed, Shlomo [1 ]
机构
[1] Cedars Sinai Med Ctr, Dept Med, Pituitary Ctr, Los Angeles, CA 90048 USA
来源
关键词
GROWTH-HORMONE-SECRETION; RAT ANTERIOR-PITUITARY; INTRACELLULAR FREE CALCIUM; MESSENGER-RNA EXPRESSION; ADENOMAS IN-VITRO; GENE-EXPRESSION; TUMOR-CELLS; QUANTITATIVE-ANALYSIS; PROLACTIN SECRETION; CUSHINGS-DISEASE;
D O I
10.1016/j.tem.2009.12.003
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Somatotropin-release inhibitory factor (SRIF) is a major regulator of pituitary function, mostly inhibiting hormone secretion and to a lesser extent pituitary cell growth. Five SRIF receptor subtypes (SSTR1-5) are ubiquitously expressed G-protein coupled receptors. In the pituitary, SSTR1, 2, 3 and 5 are expressed, with SSTR2 and SSTR5 predominating. As new SRIF analogs have recently been introduced for treatment of pituitary disease, we evaluate the current knowledge of cell-specific pituitary SRIF receptor signaling and highlight areas of future research for comprehensive understanding of these mechanisms. Elucidating pituitary SRIF receptor signaling enables understanding of pituitary hormone secretion and cell growth, and also encourages future therapeutic development for pituitary disorders.
引用
收藏
页码:123 / 133
页数:11
相关论文
共 50 条
  • [41] HETEROGENEOUS EXPRESSION OF 2 SOMATOSTATIN RECEPTOR SUBTYPES IN PITUITARY-TUMORS
    GREENMAN, Y
    MELMED, S
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 78 (02): : 398 - 403
  • [42] Immunohistochemical detection of somatostatin receptor subtypes in “clinically nonfunctioning” pituitary adenomas
    Marek Pawlikowski
    Hanna Pisarek
    Jolanta Kunert-Radek
    Andrezej Radek
    Endocrine Pathology, 2003, 14 (3) : 231 - 238
  • [43] Constitutive Somatostatin Receptor Activity Determines Tonic Pituitary Cell Response
    Ben-Shlomo, Anat
    Zhou, Cuiqi
    Pichurin, Oxana
    Chesnokova, Vera
    Liu, Ning-Ai
    Culler, Michael D.
    Melmed, Shlomo
    MOLECULAR ENDOCRINOLOGY, 2009, 23 (03) : 337 - 348
  • [44] Immunohistochemical detection of somatostatin receptor subtypes in "clinically nonfunctioning" pituitary adenomas
    Pawlikowski, M
    Pisarek, H
    Kunert-Radek, J
    Radek, A
    ENDOCRINE PATHOLOGY, 2003, 14 (03) : 231 - 238
  • [45] Expression of somatostatin receptor subtypes in human pituitary adenomas - immunohistochemical studies
    Pisarek, Hanna
    Pawlikowski, Marek
    Kunert-Radek, Jolanta
    Radek, Maciej
    ENDOKRYNOLOGIA POLSKA, 2009, 60 (04) : 240 - 251
  • [46] STRUCTURAL CHARACTERIZATION OF THE SOMATOSTATIN RECEPTOR IN RAT ANTERIOR-PITUITARY MEMBRANES
    LEWIS, LD
    WILLIAMS, JA
    ENDOCRINOLOGY, 1987, 121 (02) : 486 - 492
  • [47] Mapping of somatostatin receptor types in GH or/and PRL producing pituitary adenomas
    Thodou, E
    Kontogeorgos, G
    Theodossiou, D
    Pateraki, M
    JOURNAL OF CLINICAL PATHOLOGY, 2006, 59 (03) : 274 - 279
  • [48] COVALENT LABELING OF THE SOMATOSTATIN RECEPTOR IN RAT ANTERIOR-PITUITARY MEMBRANES
    BRUNO, JF
    BERELOWITZ, M
    ENDOCRINOLOGY, 1989, 124 (02) : 831 - 837
  • [49] PITUITARY ACTIONS OF SOMATOSTATIN
    SNOW, MH
    SCANLON, MF
    MORA, B
    HEATH, M
    HALL, R
    GOMEZPAN, A
    ANNALS OF CLINICAL RESEARCH, 1978, 10 (03): : 145 - 150
  • [50] PITUITARY EFFECTS OF SOMATOSTATIN
    HALL, R
    SNOW, M
    SCANLON, M
    MORA, B
    GOMEZPAN, A
    METABOLISM-CLINICAL AND EXPERIMENTAL, 1978, 27 (09): : 1257 - 1262